| beyond randomized controlled trials: a "real life" experience of respiratory syncytial virus infection prevention in infancy with and without palivizumab. | a population-based study of the impact of palivizumab on confirmed respiratory syncytial virus (rsv) hospitalizations over a 7-year period within and between two similar health regions . clinicians in calgary implemented palivizumab prophylaxis for high-risk infants during the last four rsv seasons; clinicians in edmonton did not. the two cities are part of a unified health care system and similar sociodemographics. infants <36 weeks (wk) of gestational age (ga) were identified. rsv prophylaxis ... | 2006 | 17058279 |